Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew K. Chan currently holds 239,747 shares of Cellular Biomedicine Group, Inc. (CBMG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew K. Chan has been a net seller of CBMG stock. They have purchased $100.0K and sold $1.3M worth of shares.
Andrew K. Chan's most recent insider trade was on Feb 19, 2021, when they sold 48,000 shares at $0.00 per share.
Andrew K. Chan serves as Executive at Cellular Biomedicine Group, Inc. (CBMG). They have executed 56 insider transactions totaling $1.4M over their tenure at the company.
Andrew K. Chan holds the position of Executive at Cellular Biomedicine Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Andrew K. Chan has shown a selling trading pattern, with $100.0K in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew K. Chan was on Dec 18, 2015, when they sold $220.0K worth of CBMG shares. This transaction involved 10,000 shares at $22.00 per share.
Andrew K. Chan currently owns 239,747 shares of Cellular Biomedicine Group, Inc. (CBMG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew K. Chan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew K. Chan has 56 Form 4 filings on record as an insider at Cellular Biomedicine Group, Inc..
Set alerts for Andrew K. Chan and 40,000+ other insiders.